Related Experiment Video
Updated: Jun 3, 2026

Method of Studying Palatal Fusion using Static Organ Culture
Published on: September 19, 2015
Whole blood propionylcarnitine in newborns with orofacial cleft
Kamil K Hozyasz1, Mariusz Oltarzewski, Iwona Lugowska
1Departments of Pediatrics, Pediatric Surgical Oncology and Pediatric Surgery and Neonatal Screening Laboratory, Institute of Mother and Child, Warsaw, Poland. khozyasz@verco.com.pl
Insights
This study found no significant difference in propionylcarnitine levels between newborns with orofacial clefts and controls. Maternal vitamin B12 deficiency, indicated by elevated propionylcarnitine, does not appear to be a risk factor for cleft lip and palate.
Area of Science:
- Biochemistry
- Genetics
- Developmental Biology
Background:
- Orofacial clefts result from complex genetic and environmental interactions.
- Vitamin B12 plays a role in preventing certain birth defects, as shown in animal studies.
- Elevated propionylcarnitine in newborns suggests maternal vitamin B12 deficiency.
Purpose of the Study:
- To investigate the association between increased propionylcarnitine levels in newborns and orofacial clefts.
- To determine if maternal vitamin B12 deficiency is a risk factor for cleft lip with or without cleft palate (CLP).
Main Methods:
- A retrospective study comparing 52 newborns with isolated CLP to 107 unaffected control newborns.
- Whole blood propionylcarnitine concentrations were quantified using tandem mass spectrometry.
- Statistical analysis using a T-test for equality of means was performed.
Main Results:
- The mean propionylcarnitine concentration in newborns with clefts was 2.82±1.06µmolL⁻¹.
- The mean propionylcarnitine concentration in control newborns was 2.68±0.94µmolL⁻¹.
- No statistically significant difference was found between the two groups (P=0.381).
Conclusions:
- Maternal vitamin B12 deficiency, indicated by elevated propionylcarnitine, does not appear to be a significant risk factor for CLP in this study population.
- Further research may be needed to fully elucidate the role of vitamin B12 in orofacial cleft development.
Abstract:
Orofacial clefts are thought to be determined by the interplay of genetic and environmental factors. Experiments on animals demonstrated that vitamin B12 supplemented diets antagonize selected teratogens during palatogenesis. Increased propionylcarnitine in neonates is regarded as a marker of maternal vitamin B12 deficiency. The retrospective study was undertaken to determine whether increased propionylcarnitine in newborns is associated with orofacial clefts. Fifty-two newborns with isolated cleft lip with or without cleft palate (CLP) and 107 control newborns without congenital anomalies were investigated. Whole blood propionylcarnitine concentrations were measured using tandem mass spectrometry. The mean concentrations of propionylcarnitine in newborns with clefts and controls were 2.82±1.06µmolL(-1) and 2.68±0.94µmolL(-1), respectively. T-test for equality of means did not confirm any significant differences between both groups (P=0.381). Deficiency of vitamin B12 with metabolic disturbances seems not to be a risk factor for CLP in the investigated group of patients.
Related Concept Videos
Development of the Oral Microbiota
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...

